The Institute for OneWorld Health (IOWH) is a nonprofit pharmaceutical company. This brochure was created to help tell their story and demonstrate that nonprofit pharmaceutical companies can develop safe, effective and affordable new medicines for people with infectious diseases in the developing world. IOWH did just that with their first approved drug, paromomycin, for the treatment of visceral leishmaniasis (more commonly known as VL or black fever). 20 pages, 10 x 15, saddle-stitched, 4-color throughout.
